Ahead of the High-Level Meeting on TB, Médecins Sans Frontières will host a webinar on 8 September 2023 to provide information about the next phase of the Time for $5 Campaign, calling on the diagnostics company Cepheid and its parent corporation Danaher to reduce the price of the GeneXpert test cartridge to $5.

Access to medicines issues finally back on negotiators’ agenda after being sidelined for more than a year

Analysis of health R&D pipeline shows important progress, but significant gaps in innovation remain

For the first time, children in Tajikistan with multidrug-resistant tuberculosis (MDR-TB) are receiving treatment for the life-threatening disease. Doctors Without Borders/Médecins Sans Frontières (MSF) has opened a new ward in Machiton hospital, near Tajikistan's capital of Dushanbe, where it plans to treat 60 to 100 children with TB, plus their family members, over the next three months.

In northwestern Uzbekistan, drug-resistant forms of tuberculosis (TB) are spreading while only one in 10 people with TB receives treatment. Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 2,000 people with drug-resistant TB in Uzbekistan over the last 10 years.

"Losing Ground" describes the impact of funding shortfalls in critical areas of HIV and TB in 13 countries where MSF work.

Bangkok, Thailand 22 February 2012 – In a report released today Médecins Sans Frontières (MSF), the largest provider of HIV treatment in Myanmar (1), highlights the critical need for increased HIV and Tuberculosis (TB), including multidrug-resistant tuberculosis (MDR-TB), treatment in the country.